5487 |
The 20th Anniversary of TAVR Ceremony - From Concept to Human Application |
Alain G. Cribier |
Aug. 01. 22 |
5486 |
PCSK9 Inhibitor: Effect of Alirocumab on CV Events and Mortality After ACS |
Hanbit Park |
Apr. 08. 22 |
5485 |
Landscape of Lipid Management Following an ACS Event |
Choongki Kim |
Apr. 08. 22 |
5484 |
How is SAPIEN 3 Valve Design Connected to Clinical Benefit? |
Young-Guk Ko |
Apr. 08. 22 |
5483 |
Strategies of IVUS-Guided Left Main PCI with SYNERGY MEGATRON¢â BP Stent |
Jeehoon Kang |
Apr. 08. 22 |
5482 |
SYNERGY MEGATRON – Advancing Your Large Proximal Vessel Strategy for Improved Outcomes |
Huay Cheem Tan |
Apr. 08. 22 |
5481 |
Comparison of 2 Different Paclitaxel-coated Balloons in Coronary In-stent Restenosis: A Randomized Controlled Trial |
Eun-Seok Shin |
Apr. 08. 22 |
5480 |
Influence of Baseline HbA1c and Antiplatelet Therapy on 1-year Vein Graft Outcome |
Qiang Zhao |
Apr. 08. 22 |
5479 |
Sex Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiologic Significance |
Bon-Kwon Koo |
Apr. 08. 22 |
5478 |
Case IV: STEMI and Intracranial Hemorrhage: Double Trouble |
Amir Aziz Alkatiri |
Apr. 08. 22 |